EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Access to ketogenic dietary therapies for drug-resistant epilepsy in Italy: Insights from a LICE national survey

Tullio Messana, Nicolas Battistella, Valentina Biagioli, Francesca Darra, Alice Dianin, Beatrice Di Tella, Elia Domenica, Silvia Masnada, Sara Matricardi, Francesca Operto, Isabella Orlando, Nicola Pietrafusa und 5 weitere

Epilepsy & Behavior · 2026

DOI: 10.1016/j.yebeh.2026.111304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026. Verfasst von Tullio Messana und 16 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria Dell'etá Pediatrica, Full Member of the ERN Epicare, Bologna, Italy. Hauptthemen laut MEDLINE: Diet, Ketogenic, Drug Resistant Epilepsy, Health Services Accessibility. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Ketogenic dietary therapies (KDTs) are an established treatment option for drug-resistant epilepsy (DRE), yet their implementation in routine clinical practice remains heterogeneous. We conducted a national survey promoted by the Italian League Against Epilepsy (LICE) Dietary Therapy Study Group to evaluate current KDT practice, identify barriers to implementation, and explore future organizational and educational needs across Italian epilepsy centers. METHODS: A cross-sectional anonymous electronic survey was distributed to healthcare professionals working in LICE-affiliated epilepsy centers. The questionnaire investigated respondent characteristics, institutional setting, multidisciplinary resources, KDT implementation, organizational models, perceived barriers, and future training needs. Comparisons between pediatric and adult services were performed using chi-square or Fisher's exact tests, as appropriate. Odds ratios (OR) with 95 % confidence intervals (CI) were calculated. A multivariable logistic regression model was used to identify factors independently associated with direct KDT implementation. RESULTS: Seventy-nine completed questionnaires were included. Respondents were predominantly adult neurologists (59.4 %), while 49.3 % worked in tertiary referral centers. Direct KDT implementation was reported by 46.8 % of centers, whereas 15.1 % relied on referral pathways and 31.6 % expressed interest in establishing a KDT program. Organizational barriers emerged as the principal limitations, particularly lack of dedicated personnel and insufficient multidisciplinary expertise (76 and 80 % respectively). Patient- and caregiver-related adherence difficulties were the most frequently perceived barriers to treatment acceptance (70.8 % and 68.3 %, respectively), whereas adverse effects were rarely considered a major obstacle (6.3 %). Pediatric centers more frequently implemented KDTs directly than adult centers (68.8 % vs 31.9 %; OR 4.69, 95 % CI 1.78-12.34). In multivariable analysis, pediatric setting and Level III center status were independently associated with direct KDT implementation. Interest in future educational initiatives was high, with nearly 90 % of respondents supporting dedicated training programs and simplified ketogenic protocols to facilitate implementation. SIGNIFICANCE: Despite increasing evidence and national recommendations supporting KDT use in DRE, substantial organizational and educational barriers continue to limit their widespread implementation in Italy. Strengthening multidisciplinary teams, expanding training opportunities, standardizing care pathways, and developing scalable hub-and-spoke models may improve equitable access to KDTs across the national epilepsy network.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicDrug Resistant EpilepsyHealth Services AccessibilityHumansItalyCross-Sectional StudiesMaleSurveys and QuestionnairesFemaleAdult

Stichwörter der Autor:innen

AdherenceDrug-resistant epilepsyKetogenic dietary therapiesMultidisciplinary careSurvey

Autor:innen und Institutionen

  • Istituto Delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria Dell'etá Pediatrica, Full Member of the ERN Epicare, Bologna, Italy.
  • Department of Brain and Behaviour Neuroscience, University of Pavia, Pavia, Italy.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Italy.
  • Child Neuropsychiatry Unit, Department of Engineering for Innovation Medicine, University of Verona, Full Member of European Reference Network EpiCARE, Verona, Italy.
  • Inherited Metabolic Diseases Unit and Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, Azienda Ospedaliera Universitaria Integrata, Verona…
  • IRCCS Istituto Delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria Dell'etá Pediatrica, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Università di Bologna, Bologna, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Messana, T., Battistella, N., Biagioli, V., Darra, F., Dianin, A., Di Tella, B., Domenica, E., Masnada, S., Matricardi, S., Operto, F., Orlando, I., Pietrafusa, N., Ragona, F., Russo, E., Veggiotti, P., Volpi, L., & De Giorgis, V. (2026). Access to ketogenic dietary therapies for drug-resistant epilepsy in Italy: Insights from a LICE national survey. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2026.111304

Vancouver

Messana T, Battistella N, Biagioli V, Darra F, Dianin A, Di Tella B, et al. Access to ketogenic dietary therapies for drug-resistant epilepsy in Italy: Insights from a LICE national survey. Epilepsy & Behavior. 2026. doi:10.1016/j.yebeh.2026.111304

BibTeX
@article{Messana2026,
  author = {Messana, Tullio and Battistella, Nicolas and Biagioli, Valentina and Darra, Francesca and Dianin, Alice and Di Tella, Beatrice and Domenica, Elia and Masnada, Silvia and Matricardi, Sara and Operto, Francesca and Orlando, Isabella and Pietrafusa, Nicola and Ragona, Francesca and Russo, Emilio and Veggiotti, Pierangelo and Volpi, Lilia and De Giorgis, Valentina},
  title = {Access to ketogenic dietary therapies for drug-resistant epilepsy in Italy: Insights from a LICE national survey},
  journal = {Epilepsy & Behavior},
  year = {2026},
  doi = {10.1016/j.yebeh.2026.111304}
}
Kostenlos starten →